Answers are grounded in this paper and cite their sources.
Background Although the repertoire of systemic therapies for advanced hepatocellular carcinoma (HCC) continues to expand, patient outcomes remain highly variable and often suboptimal. Emerging evidence suggests that treatment efficacy is significantly influenced by the underlying disease aetiology and specific genetic mutations. Objective Developing scalable preclinical models that accurately reflect human HCC subtypes to advance precision medicine in HCC. Design We employed HCC tumours induced via hydrodynamic tail vein injection of various proto-oncogene and tumour suppressor gene combinations in mice, complemented by a tumour organoid platform, to explore drug repurposing strategies by leveraging driver mutations as biomarkers and to characterise the features of HCC driven by distinct genetic alterations. Results High-throughput screening identified ERBB family inhibitors as promising therapeutic candidates for CTNNB1 mutation-driven HCC. Multi-omics analyses, including chromatin accessibility, transcriptomics and phosphoproteomics, revealed that CTNNB1 mutations upregulate FOXA2 expression, which functions as a transcriptional activator of ERBB signalling-related genes such as EGFR and TGFA, thereby activating the ERBB pathway. Clinically, patients with HCC harbouring CTNNB1 mutations displayed increased FOXA2 expression and ERBB pathway activation. As a proof of concept, treatment with ERBB inhibitors effectively suppressed tumour growth in vivo in mouse models and ex vivo in patient-derived organoids, specifically in HCC driven by CTNNB1 mutations but not in tumours with TP53 mutations. Conclusion Our findings uncover a novel mechanism by which β-catenin activates ERBB signalling in HCC and provide a foundation for repurposing existing drugs, such as gefitinib or afatinib, as targeted therapies for patients with CTNNB1-mutant HCC.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: